AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 112 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,805,732 | +373.3% | 254,564 | +160.6% | 0.00% | – |
| Q3 2022 | $804,000 | +26.2% | 97,689 | +0.6% | 0.00% | – |
| Q2 2022 | $637,000 | +17.3% | 97,089 | 0.0% | 0.00% | – |
| Q1 2022 | $543,000 | +30.2% | 97,089 | +9.2% | 0.00% | – |
| Q4 2021 | $417,000 | -24.0% | 88,895 | 0.0% | 0.00% | – |
| Q3 2021 | $549,000 | -13.3% | 88,895 | -7.4% | 0.00% | – |
| Q2 2021 | $633,000 | -72.6% | 95,995 | -69.5% | 0.00% | – |
| Q1 2021 | $2,307,000 | +43.6% | 315,187 | +13.3% | 0.00% | – |
| Q4 2020 | $1,606,000 | +41.6% | 278,267 | +45.7% | 0.00% | – |
| Q3 2020 | $1,134,000 | +67.5% | 190,934 | +45.2% | 0.00% | – |
| Q2 2020 | $677,000 | – | 131,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |